Intelligent Bio Solutions Inc (INBS) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Intelligent Bio Solutions Inc   (NASDAQ: INBS)
 

Intelligent Bio Solutions Inc Growth Comparisons

Select each growth Category to receive further Information





INBS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 35.78 % 6.57 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 8.01 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 38.09 % 7.21 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 7.72 % 1.5 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 86.13 % 10.68 % 8.65 % 10.59 %


INBS's Growth Comparisons in IV. Quarter 2026




Facing 35.78% year on year sales decrease in the fourth quarter 2026, to $ 1 millions, Intelligent Bio Solutions Inc reported smaller declines than the Medical Equipment & Supplies industry with 6.57%, and less than 8.91% growth in the Healthcare sector. Despite the modest Sales rises in theHealthcare sector and the Medical Equipment & Supplies industry, Intelligent Bio Solutions Inc reported above average market Sales growth.

Comparing the company's Revenue to the third quarter results, sales were higher by 8.01% . On the yearly basis, average annual sales growth for Intelligent Bio Solutions Inc is 86.13%, while S & P 500's including only Businesses with the fourth quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

INBS Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Sales of Goods Cartidges
-
-
UNITED KINGDOM
-
-20.57 %
GB
-
-
Other Country
-
236.5 %
Total
-49 %
8.03 %


Growth Rates of INBS's Income in the fourth quarter 2026


INBS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 11.6 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 13.68 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - 2.92 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -10.42 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 16.79 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) - -2.7 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 0.17 % -28.52 %

INBS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -12.37 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - 44.98 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) - -0.27 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) - -3.32 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth - 4.12 % 9.21 % 22.96 %

INBS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -16.23 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -1.8 % 0.17 % -28.52 %



INBS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -18.05 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - 40.16 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 4.12 % 9.21 % 22.96 %



Intelligent Bio Solutions Inc reported bottom-line of $ -2.65 in the fourth quarter, compare to $ -5.86 in the same quarter a year ago. Medical Equipment & Supplies industry fell by -18.05%, while Healthcare sector decreased by -26.26%, and overall market improved by 90.69%.

Comparing company's EPS to the third quarter results, income per share were higher by 8.01% . On the yearly basis, average annual income per share growth for Intelligent Bio Solutions Inc is 86.13%, while S & P 500's including only the businesses with the fourth quarter 2026 Results, average annual income per share growth is 22.96% over the past five years.

INBS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 63.77 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) - -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) - 39.68 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) - 8.02 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 66.93 % -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) - -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 5.56 % -1.63 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -46 % -1.55 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 8.3 % 9.18 % 14.72 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.